17 related articles for article (PubMed ID: 30381672)
1. Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study.
Kataoka S; Nishikawa Y; Funakoshi T; Horimatsu T; Sakuragi M; Uchino E; Hiragi S; Yamamoto S; Sakai K; Matsubara T; Yanagita M; Muto M
Int J Clin Oncol; 2024 Apr; 29(4):398-406. PubMed ID: 38351273
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival and renal dysfunction in a patient with recurrent colorectal cancer treated with Bevacizumab.
Kataoka S; Nishikawa Y; Funakoshi T; Horimatsu T; Kondo N; Matsubara T; Yanagita M; Matsumoto S; Muto M
Clin J Gastroenterol; 2020 Jun; 13(3):316-319. PubMed ID: 31707696
[TBL] [Abstract][Full Text] [Related]
3. The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.
Bi Y; Zhu D; Cheng J; Zhu Y; Xu N; Cui S; Li W; Cheng X; Wang F; Hu Y; Shen S; Weng J
Clin Ther; 2010 May; 32(5):973-83. PubMed ID: 20685506
[TBL] [Abstract][Full Text] [Related]
4. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
[TBL] [Abstract][Full Text] [Related]
5. The association of elevated HbA1c on the behavior of adenomatous polyps in patients with type-II diabetes mellitus.
Siddiqui AA; Maddur H; Naik S; Cryer B
Dig Dis Sci; 2008 Apr; 53(4):1042-7. PubMed ID: 17939046
[TBL] [Abstract][Full Text] [Related]
6. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
Sany D; Elshahawy Y; Anwar W
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
[TBL] [Abstract][Full Text] [Related]
7. Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated Cancer Patients with Type 2 Diabetes Mellitus.
Chiba T; Nihei S; Komatsu H; Obara M; Ishigaki Y; Sasaki A; Kudo K
Biol Pharm Bull; 2018; 41(11):1722-1726. PubMed ID: 30381672
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: An analysis of the literature.
Tipping M; Eickhoff J; Ian Robins H
J Clin Neurosci; 2017 Oct; 44():101-106. PubMed ID: 28711289
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
